Literature DB >> 26471011

Structure-function Relationships in Uveitic Cystoid Macular Edema: Using En Face Optical Coherence Tomography to Predict Vision.

Liza M Cohen1, Debra A Goldstein1, Amani A Fawzi1.   

Abstract

PURPOSE: To explore whether preserved retinal tissue on baseline en face optical coherence tomography (OCT) correlates with post-treatment visual acuity in patients with uveitis-associated cystoid macular edema (CME).
METHODS: A retrospective cohort study was conducted on 25 eyes (23 patients) with uveitis and CME, with resolution of CME at post-treatment follow-up. Baseline en face OCT images were analyzed to determine the proportion of pixels representing preserved retinal tissue. Macular thickness and volume data were also analyzed.
RESULTS: The proportion of preserved retinal tissue on baseline OCT strongly correlated with baseline visual acuity (r = 0.61, p = 0.0014), and correlated even better with vision after CME resolution (r = 0.73, p < 0.0001). Weak correlations were found between macular thickness and volume at baseline and post-treatment acuity (r = 0.38, p = 0.058 and r = 0.39, p = 0.055).
CONCLUSIONS: Preserved retinal tissue at baseline strongly correlates with post-treatment visual acuity in patients with uveitis-associated CME, and is a better predictor of future vision than macular thickness or volume.

Entities:  

Keywords:  Cystoid macular edema; image analysis; optical coherence tomography; retina; uveitis

Mesh:

Substances:

Year:  2015        PMID: 26471011     DOI: 10.3109/09273948.2015.1056535

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  1 in total

1.  Measurement of the active toxoplasma retinochoroiditis lesion size during the disease course with swept-source optical coherence tomography angiography: A retrospective image analysis.

Authors:  Ferdane Atas; Mahmut Kaya; Tugce Toprak; Betul Akbulut Yagci; Alper Selver; Ali Osman Saatci
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.